Literature DB >> 29656062

The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysis.

Nikolaos Andreatos1, Fadi Shehadeh1, Elina Eleftheria Pliakos1, Eleftherios Mylonakis2.   

Abstract

OBJECTIVES: To investigate the association of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection with socioeconomic factors and antibiotic prescriptions at the county level.
METHODS: MRSA bloodstream infection rates were extracted from the Medicare Hospital Compare database. Data on socioeconomic factors and antibiotic prescriptions were obtained from the US Census Bureau and the Medicare Part D database, respectively.
RESULTS: In multivariate analysis, antibiotic prescriptions demonstrated a powerful positive association with MRSA bloodstream infection rates [Coefficient (Coeff): 0.432, 95% Confidence Interval (CI): 0.389, 0.474, P < 0.001], which was largely attributable to lincosamides (Coeff: 0.257, 95% CI: 0.177, 0.336, P < 0.001), glycopeptides (Coeff: 0.223, 95% CI: 0.175, 0.272, P < 0.001), and sulfonamides (Coeff: 0.166, 95% CI: 0.082, 0.249, P < 0.001). Sociodemographic factors, such as poverty (Coeff: 0.094, 95% CI: 0.034, 0.155, P=0.002) exerted a secondary positive impact on MRSA bloodstream infection. Conversely, college education (Coeff: -0.037, 95% CI: -0.068, -0.005, P=0.024), a larger median room number per house (Coeff: -0.107, 95% CI: -0.134, -0.081, P < 0.001), and an income above the poverty line (100% < income < 150% of the poverty line) (Coeff: -0.257, 95% CI: -0.314, -0.199, P < 0.001) were negatively associated with MRSA incidence rates. A multivariate model that incorporated socioeconomic data and antibiotic prescription rates predicted 39.1% of the observed variation in MRSA bloodstream infection rates (Pmodel < 0.001).
CONCLUSIONS: MRSA bloodstream infection rates were strongly associated with county-level antibiotic use and socioeconomic factors. If the causality of these associations is confirmed, antimicrobial stewardship programs that extend outside acute healthcare facilities would likely prove instrumental in arresting the spread of MRSA.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  MRSA; antibiotics; county; infection; poverty

Mesh:

Substances:

Year:  2018        PMID: 29656062     DOI: 10.1016/j.ijantimicag.2018.04.003

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Identifying patient-level risk factors associated with non-β-lactam resistance outcomes in invasive MRSA infections in the United States using chain graphs.

Authors:  William J Love; C Annie Wang; Cristina Lanzas
Journal:  JAC Antimicrob Resist       Date:  2022-07-05

2.  Eco-friendly synthesis of functionalized chitosan-based nanoantibiotic system for potential delivery of linezolid as antimicrobial agents.

Authors:  Mahmoud H Teaima; Mohamed K Elasaly; Samia A Omar; Mohamed A El-Nabarawi; Kamel R Shoueir
Journal:  Saudi Pharm J       Date:  2020-06-18       Impact factor: 4.330

3.  Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program.

Authors:  Daniel J Diekema; Michael A Pfaller; Dee Shortridge; Marcus Zervos; Ronald N Jones
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

4.  Development of Antimicrobial Stewardship Programmes in Low and Middle-Income Countries: A Mixed-Methods Study in Nigerian Hospitals.

Authors:  Eneyi E Kpokiri; David G Taylor; Felicity J Smith
Journal:  Antibiotics (Basel)       Date:  2020-04-23

5.  Changing epidemiology of methicillin-resistant Staphylococcus aureus in a low endemicity area-new challenges for MRSA control.

Authors:  Jenna Junnila; Tiina Hirvioja; Esa Rintala; Kari Auranen; Kaisu Rantakokko-Jalava; Jaakko Silvola; Laura Lindholm; Kirsi Gröndahl-Yli-Hannuksela; Harri Marttila; Jaana Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-27       Impact factor: 3.267

6.  Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Hospitalizations: National Inpatient Sample, 2016-2019.

Authors:  Eili Y Klein; Xianming Zhu; Molly Petersen; Eshan U Patel; Sara E Cosgrove; Aaron A R Tobian
Journal:  Open Forum Infect Dis       Date:  2021-11-22       Impact factor: 4.423

7.  Socioeconomic Status and Determinants of Pediatric Antibiotic Use.

Authors:  Andrew McGurn; Brittany Watchmaker; Kaavya Adam; Jeff Ni; Piotr Babinski; Hannah Friedman; Bridget Boyd; Lara R Dugas; Talar Markossian
Journal:  Clin Pediatr (Phila)       Date:  2020-08-04       Impact factor: 1.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.